A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities-Reference-Cited by-同舟云学术

A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities

Published:2015-04-29 Issue:8 Volume:54 Page:1195-1201
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Haas Rick L. M.,Gelderblom Hans,Sleijfer Stefan,van Boven Hester H.,Scholten Astrid,Dewit Luc,Borst Gerben,van der Hage Jos,Kerst J. Martijn,Nout Remi A.,Hartgrink Henk H.,de Pree Ilse,Verhoef Cornelis,Steeghs Neeltje,van Coevorden Frits

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2015.1037404

Reference28 articles.

1. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial

2. Radiotherapy for Management of Extremity Soft Tissue Sarcomas: Why, When, and Where?

3. VEGF targets the tumour cell

4. Pazopanib, a new therapy for metastatic soft tissue sarcoma

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathologic complete response in patients with localized soft tissue sarcoma treated with neoadjuvant therapy and its correlation with clinical outcomes: A systematic review;Cancer Treatment Reviews;2024-11

2. Preoperative sequential chemotherapy and hypofractionated radiotherapy combined with comprehensive surgical resection for high-risk soft tissue sarcomas: a retrospective study;Frontiers in Oncology;2024-06-19

3. Dual effects of radiotherapy on tumor microenvironment and its contribution towards the development of resistance to immunotherapy in gastrointestinal and thoracic cancers;Frontiers in Cell and Developmental Biology;2023-10-03

4. Local Therapies for Metastatic Sarcoma: Why, When, and How?;American Society of Clinical Oncology Educational Book;2023-06

5. Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG Oncology;Journal of Surgical Oncology;2023-02-13